Aggressive T-cell lymphoma is a rare and devastating form of blood cancer with a very low five-year survival rate. Read more
Medical News - Dec 09
Using a versatile problem-solving framework, researchers show how early relapse in lymphoma patients influences their chance for survival. Read more
Massachusetts Institute Of Technology - Dec 08
Tuberculosis (TB) continues to be one of the world's leading causes of infectious disease-related illness and death. Despite being treatable, gaps in screening and diagnosis have allowed the disease to persist as a major global health threat. In regions like Southeast Asia, where TB rates remain ... Read more
Medical Xpress - Nov 12
Researchers from Mass General Brigham have unveiled the results of a large clinical trial that found that adding the drug evolocumab to patients' treatment significantly reduced the risk of major adverse cardiovascular events in those who are at high risk. Results were presented today at the Amer... Read more
Medical Xpress - Nov 09
(MedPage Today) -- NEW ORLEANS – Standard medical care seemed to be a better bet than a catheter-based procedure in high-risk patients with atrial fibrillation (Afib), according to the CLOSURE-AF study.The trial had a composite primary... Read more
Medpagetoday - Nov 09
BAE Systems and Forterra have joined hands to develop a highly survivable, self-driving AMPV prototype at speeds that rapidly outpace traditional development cycles. Read more
Interesting Engineering - Oct 03
The US Scenario Modeling Hub’s nine-team ensemble projected COVID-19 hospitalizations and deaths for April 2024 to April 2025 under six policy and immune-escape scenarios. Burden was similar to the prior year, with universal vaccination recommendations averting more outcomes than high-risk-only g... Read more
Medical News - Sep 21
COVID-19 vaccines are now available only for high-risk groups under new FDA marketing authorization, as emergency use authorizations are officially rescinded. Read more
Fox News - Aug 27
Treatment with Verzenio plus endocrine therapy demonstrated a statistically significant and clinically meaningful improvement in overall survival compared to endocrine therapy alone In the seven-year landmark analysis of monarchE, treatment with Verzenio also resulted in sustained... Read more
Pr Newswire - Aug 27
